The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis

Gastroenterology

Volumn 145, Issue 1, 2013, Pages

  Feagan, Brian G ^a,b   Sandborn, William J ^c,d   D'Haens, Geert ^e   Pola, Suresh ^c   McDonald, John W D ^a   Rutgeerts, Paul ^f   Munkholm, Pia ^g   Mittmann, Ulrich ^h   King, Debra ^a   Wong, Cindy J ^a   Zou, Guangyong ^a,b   Donner, Allan ^a,b   Shackelton, Lisa M ^a   Gilgen, Denise ⁱ   Nelson, Sigrid ^d   Vandervoort, Margaret K ^a   Fahmy, Marianne ^c   Loftus, Edward V ^j   Panaccione, Remo ^k   Travis, Simon P ^l   Van Assche, Gert A ^m   Vermeire, Séverine ^f   Levesque, Barrett G ^c,d   Marakhouski, Yury ⁿ   Sapeha, Leanid ^o   Pimanov, Sergei ^o   Rusinovich, Valerii ^p   Mikhailova, Elena ^q   Varabei, Aliaksandr ^r   Zakharash, Mykhailo ^s   Levchenko, Olena ^t   Lozynskyy, Yuriy ^u   Datsenko, Oleksiy ^v   Stepanov, Yuriy ^w   Svintsitskyy, Anatoliy ^x   Neyko, Vasyl ^y   Kharchenko, Nataliya ^z   Simsek, Ilkay ^aa   Unsal, Belkis ^ab   Tuncer, Candan ^ac   Toruner, Murat ^ad   Sivri, Bulent ^ae   Kadayifci, Abdurrahman ^af   Alkim, Canan ^ag   Goral, Vedat ^ah   Tezel, Ahmet ^ai   Sathyaprakash, Bonthala Subbaraj ^aj   Prabhakar, Boddu ^ak   Devi, Malladi Uma ^al   Shenoy, Kotacherry Trivikrama ^am   Kalla, Mukesh ^an   Rajkumar, Janaviculam Sankaran ^ao   Kar, Premashish ^ap   more..

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Robarts Research Institute   (United States)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^h Mittmann Pharma Consulting   (Switzerland)

ⁱ Tillotts Pharma UK Ltd   (Switzerland)

^j MAYO CLINIC   (United States)

^k UNIVERSITY OF CALGARY   (Canada)

^l JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^m MOUNT SINAI HOSPITAL   (Canada)

ⁿ Hospital No 10   (Belarus)

^o Department of Cardiac Surgery Vitebsk Regional Clinical Hospital   (Belarus)

^p The 3rd Klumov Clinical Hospital   (Belarus)

^q Gomel Regional Clinical Hospital   (Belarus)

^r Maternity Hospital of Minsk Region   (Belarus)

^s National Academy of Security Service of Ukraine   (Ukraine)

^t Department of Obstetrics and Gynecology   (Ukraine)

^u DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^v Kharkov City Clinical Hospital   (Ukraine)

^w Dnipropetrovsk State Medical Academy   (Ukraine)

^x BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^y IVANO FRANKIVSK NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^z SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

^aa DOKUZ EYLUL UNIVERSITY   (Turkey)

^ab ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^ac GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^ad ANKARA UNIVERSITY   (Turkey)

^ae HACETTEPE UNIVERSITY   (Turkey)

^af GAZIANTEP UNIVERSITY   (Turkey)

^ag SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^ah DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^ai TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^aj Ramajah Medical College and Hospital   (India)

^ak OSMANIA GENERAL HOSPITAL   (India)

^al Medwin Hospital   (India)

^am Sree Gokulam Medical College   (India)

^an SR Kalla Memorial Gastro and General Hospital   (India)

^ao Life Line Hospitals   (India)

^ap MAULANA AZAD MEDICAL COLLEGE   (India)

more..

Author keywords

Central Reading; Inflammatory Bowel Disease; Interobserver Agreement; Therapy

Indexed keywords

MESALAZINE; PLACEBO;

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; DELAYED DRUG RELEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPY; FECES CULTURE; FEMALE; HUMAN; IMAGE ANALYSIS; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; READING; REMISSION; RISK ASSESSMENT; SIGMOIDOSCOPY; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

EID: 84879485530     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.03.025     Document Type: Article

References (38)

1. A. Kornbluth, D.B. Sachar, and Practice Parameters Committee of the American College of Gastroenterology Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee Am J Gastroenterol 105 2010 501 523
2. C. Mowat, A. Cole, A. Windsor IBD Section of the British Society of Gastroenterology Guidelines for the management of inflammatory bowel disease in adults Gut 60 2011 571 607
3. A. Dignass, R. Eliakim, and F. Magro Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management J Crohns Colitis 6 2012 991 1030
4. B.G. Feagan, and J.K. MacDonald Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis Cochrane Database Syst Rev 10 2012 CD000543
5. S.B. Hanauer, D. Ramsey, and W.J. Sandborn Efficacy of delayed-release oral mesalamine in patients who received previous ulcerative colitis treatment Gastroenterology 134 Suppl 1 2008 A490
6. W.J. Sandborn, J. Regula, and B.G. Feagan Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis Gastroenterology 137 2009 1934 1943
7. W.J. Sandborn, D. Ramsey, and C. Sninsky Rapid symptom resolution with delayed release mesalamine 4.8g/d compared to 2.4 g/d in moderately active ulcerative colitis patients with a history of more difficult to treat disease Am J Gastroenterol 104 Suppl 3 2009 A1209
8. M.A. Kamm, G.R. Lichtenstein, and W.J. Sandborn Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis Inflamm Bowel Dis 15 2009 1 8
9. B.G. Feagan, and J.K. MacDonald Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: a systematic review and meta-analysis Inflamm Bowel Dis 18 2012 1785 1794
10. M.A. Kamm, W.J. Sandborn, and M. Gassull Once-daily, high-concentration MMX mesalamine in active ulcerative colitis Gastroenterology 132 2007 66 75
11. G.R. Lichtenstein, M.A. Kamm, and P. Boddu Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis Clin Gastroenterol Hepatol 5 2007 95 102
12. W. Kruis, G. Kiudelis, and I. Racz Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial Gut 58 2009 233 240
13. S. Kane, D. Huo, and J. Aikens Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis Am J Med 114 2003 39 43
14. S.V. Kane, D. Brixner, and D.T. Rubin The challenge of compliance and persistence: focus on ulcerative colitis J Manag Care Pharm 14 Suppl A 2008 S2 S12
15. S.V. Kane, R.D. Cohen, and J.E. Aikens Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis Am J Gastroenterol 96 2001 2929 2933
16. J.P. Ediger, J.R. Walker, and L. Graff Predictors of medication adherence in inflammatory bowel disease Am J Gastroenterol 102 2007 1417 1426
17. S.P. Travis, D. Schnell, and P. Krzeski Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) Gut 61 2012 535 542
18. L.R. Sutherland, F. Martin, and S. Greer 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis Gastroenterology 92 1987 1894 1898
19. B.G. Feagan, G.R. Greenberg, and G. Wild Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin N Engl J Med 352 2005 2499 2507
20. P. Rutgeerts, W.J. Sandborn, and B.G. Feagan Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2005 2462 2476
21. R.G. Newcombe Interval estimation for the difference between two independent proportions: Comparison of eleven methods Stat Med 17 1998 873 890
22. K. Gilder, N. Ting, and L. Tian Confidence intervals on intraclass correlation coefficients in a balanced two-factor random design J Stat Plan Inference 137 2007 1199 1212
23. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
24. G.Y. Zou Sample size formulas for estimating intraclass correlation coefficients with precision and assurance Stat Med 31 2012 3972 3981
25. M.H. Gail, and R. Simon Testing of qualitative interactions between treatment effect and patients subsets Biometrics 41 1985 361 372
26. J.A. Lewis Statistical principles for clinical trials (ICH E9): an introductory note on an international guideline Stat Med 18 1999 1903 1942
27. J.L. Fleiss, and J. Cohen The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability Edu Psychol Meas 33 1973 613 619
28. C. Su, J.D. Lewis, and B. Goldberg A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis Gastroenterology 132 2007 516 526
29. A. Achiron, S. Gicquel, and S. Miron Brain MRI lesion load quantification in multiple sclerosis: a comparison between automated multispectral and semi-automated thresholding computer-assisted techniques Magn Reson Imaging 20 2002 713 720
30. P.D. Molyneux, P.A. Brex, and C. Fogg The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study Mult Scler 6 2000 237 240
31. P.D. Molyneux, D.H. Miller, and M. Filippi Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility Neuroradiology 41 1999 882 888
32. R.C. Parodi, F. Sardanelli, and P. Renzetti Growing Region Segmentation Software (GRES) for quantitative magnetic resonance imaging of multiple sclerosis: intra- and inter-observer agreement variability: a comparison with manual contouring method Eur Radiol 12 2002 866 871
33. C. Gasperini, M. Rovaris, and M.P. Sormani Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosis Mult Scler 7 2001 27 31
34. F. Guillemin, L. Billot, and S. Boini Reproducibility and sensitivity to change of 5 methods for scoring hand radiographic damage in patients with rheumatoid arthritis J Rheumatol 32 2005 778 786
35. M. Filippi, F. Barkhof, and S. Bressi Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis Mult Scler 3 1997 226 230
36. M. Filippi, M.A. Horsfield, and S. Bressi Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques Brain 118 1995 1593 1600
37. M. Rovaris, M.A. Rocca, and M.P. Sormani Reproducibility of brain MRI lesion volume measurements in multiple sclerosis using a local thresholding technique: effects of formal operator training Eur Neurol 41 1999 226 230
38. J.T. Sharp, F. Wolfe, and M. Lassere Variability of precision in scoring radiographic abnormalities in rheumatoid arthritis by experienced readers J Rheumatol 31 2004 1062 1072